Avior Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,639
| Closed | -$133K | – | 835 |
|
|
2024
Q4 | $133K | Sell |
5,639
-1,106
| -16% | -$26K | ﹤0.01% | 813 |
|
|
2024
Q3 | $173K | Sell |
6,745
-3,185
| -32% | -$81.5K | 0.01% | 738 |
|
|
2024
Q2 | $233K | Sell |
9,930
-3,963
| -29% | -$93.1K | 0.01% | 636 |
|
|
2024
Q1 | $400K | Sell |
13,893
-3,390
| -20% | -$97.5K | 0.02% | 510 |
|
|
2023
Q4 | $567K | Sell |
17,283
-9,835
| -36% | -$323K | 0.03% | 314 |
|
|
2023
Q3 | $756K | Sell |
27,118
-13,464
| -33% | -$375K | 0.05% | 241 |
|
|
2023
Q2 | $1.38M | Buy |
40,582
+117
| +0.3% | +$3.99K | 0.09% | 157 |
|
|
2023
Q1 | $1.22M | Sell |
40,465
-5,393
| -12% | -$162K | 0.08% | 171 |
|
|
2022
Q4 | $1.29M | Buy |
45,858
+41,756
| +1,018% | +$1.18M | 0.1% | 161 |
|
|
2022
Q3 | $134K | Buy |
4,102
+3,760
| +1,099% | +$123K | 0.01% | 495 |
|
|
2022
Q2 | $10K | Sell |
342
-3
| -0.9% | -$88 | ﹤0.01% | 768 |
|
|
2022
Q1 | $15K | Buy |
345
+1
| +0.3% | +$43 | ﹤0.01% | 759 |
|
|
2021
Q4 | $21K | Buy |
344
+186
| +118% | +$11.4K | ﹤0.01% | 691 |
|
|
2021
Q3 | $11K | Sell |
158
-81
| -34% | -$5.64K | ﹤0.01% | 752 |
|
|
2021
Q2 | $22K | Buy |
239
+84
| +54% | +$7.73K | ﹤0.01% | 637 |
|
|
2021
Q1 | $13K | Buy |
155
+2
| +1% | +$168 | ﹤0.01% | 717 |
|
|
2020
Q4 | $14K | Buy |
153
+78
| +104% | +$7.14K | ﹤0.01% | 662 |
|
|
2020
Q3 | $4K | Hold |
75
| – | – | ﹤0.01% | 755 |
|
|
2020
Q2 | $3K | Buy |
+75
| New | +$3K | ﹤0.01% | 748 |
|